Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The investigators recently observed that up to 25% of women with X-linked
adrenoleukodystrophy (ALD) have moderate to severe Restless Leg Syndrome (RLS). In this
study, the investigators aim to estimate the prevalence of RLS among women with ALD and to
assess whether pramipexole improves RLS symptoms as well as sleep and gait measures in women
with ALD.